90 related articles for article (PubMed ID: 38715693)
21. Serum neurofilament light chain cut-off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis.
Brousse M; Delaby C; De La Cruz E; Kuhle J; Benkert P; Mondesert E; Ginestet N; Hirtz C; Camu W; Lehmann S; Esselin F
Eur J Neurol; 2023 Jul; 30(7):1919-1927. PubMed ID: 37029777
[TBL] [Abstract][Full Text] [Related]
22. Brazilian registry of patients with porphyria: REBRAPPO study.
Souza PVS; Afonso G; de Rezende Pinto WBV; de Lima Serrano P; de Mattos Lombardi Badia B; Farias IB; Dos Santos Jorge AC; Machado RIL; Pinto IFN; Barros GB; de Oliveira HB; Calil SR; Franz C; Oliveira ASB
Orphanet J Rare Dis; 2023 Mar; 18(1):49. PubMed ID: 36890577
[TBL] [Abstract][Full Text] [Related]
23. AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.
Wang B; Bonkovsky HL; Lim JK; Balwani M
Gastroenterology; 2023 Mar; 164(3):484-491. PubMed ID: 36642627
[TBL] [Abstract][Full Text] [Related]
24. Quantifying the impact of symptomatic acute hepatic porphyria on well-being via patient-reported outcomes: Results from the Porphyria Worldwide Patient Experience Research (POWER) study.
Dickey A; Wheeden K; Lyon D; Burrell S; Hegarty S; Falchetto R; Williams ER; Barman-Aksözen J; DeCongelio M; Bulkley A; Matos JE; Mnif T; Mora J; Ko JJ; Meninger S; Lombardelli S; Nance D
JIMD Rep; 2023 Jan; 64(1):104-113. PubMed ID: 36636593
[TBL] [Abstract][Full Text] [Related]
25. Neurofilament light as a biomarker for motor decline in Parkinson's disease.
Liu Y; Dou K; Xue L; Li X; Xie A
Front Neurosci; 2022; 16():959261. PubMed ID: 36117629
[TBL] [Abstract][Full Text] [Related]
26. The multifaceted role of neurofilament light chain protein in non-primary neurological diseases.
Abu-Rumeileh S; Abdelhak A; Foschi M; D'Anna L; Russo M; Steinacker P; Kuhle J; Tumani H; Blennow K; Otto M
Brain; 2023 Feb; 146(2):421-437. PubMed ID: 36083979
[TBL] [Abstract][Full Text] [Related]
27. EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms.
Cassiman D; Kauppinen R; Monroy S; Lee MJ; Bonkovsky HL; Thapar M; Guillén-Navarro E; Minder AE; Hale C; Sweetser MT; Ivanova A
J Inherit Metab Dis; 2022 Nov; 45(6):1163-1174. PubMed ID: 36069414
[TBL] [Abstract][Full Text] [Related]
28. Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts.
Wheeden K; Lyon Howe D; Burrell S; Gill L; Chamberlayne J; Williams ER; Simon A; Ko JJ; Mora J; Wells T; Evans C; Paulich M; Meninger S; Lombardelli S
Adv Ther; 2022 Sep; 39(9):4330-4345. PubMed ID: 35907153
[TBL] [Abstract][Full Text] [Related]
29. Neurological Manifestations of Acute Porphyrias.
Wylie K; Testai FD
Curr Neurol Neurosci Rep; 2022 Jul; 22(7):355-362. PubMed ID: 35665475
[TBL] [Abstract][Full Text] [Related]
30. NfL as Analogue of C-Reactive Protein in Neurologic Diseases: Instructions for Use.
Gaetani L; Parnetti L
Neurology; 2022 May; 98(22):911-912. PubMed ID: 35418454
[No Abstract] [Full Text] [Related]
31. Neurofilament light protein as a biomarker in depression and cognitive function.
Travica N; Berk M; Marx W
Curr Opin Psychiatry; 2022 Jan; 35(1):30-37. PubMed ID: 34855695
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study.
Ventura P; Bonkovsky HL; Gouya L; Aguilera-Peiró P; Montgomery Bissell D; Stein PE; Balwani M; Anderson DKE; Parker C; Kuter DJ; Monroy S; Oh J; Ritchie B; Ko JJ; Hua Z; Sweetser MT; Sardh E;
Liver Int; 2022 Jan; 42(1):161-172. PubMed ID: 34717041
[TBL] [Abstract][Full Text] [Related]
33. Acute porphyrias - A neurological perspective.
Gerischer LM; Scheibe F; Nümann A; Köhnlein M; Stölzel U; Meisel A
Brain Behav; 2021 Nov; 11(11):e2389. PubMed ID: 34661997
[TBL] [Abstract][Full Text] [Related]
34. Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations.
de Souza PVS; Badia BML; Farias IB; Pinto WBVR; Oliveira ASB
Front Neurosci; 2021; 15():715523. PubMed ID: 34646118
[TBL] [Abstract][Full Text] [Related]
35. The potential of serum neurofilament as biomarker for multiple sclerosis.
Bittner S; Oh J; Havrdová EK; Tintoré M; Zipp F
Brain; 2021 Nov; 144(10):2954-2963. PubMed ID: 34180982
[TBL] [Abstract][Full Text] [Related]
36. Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.
Weinhofer I; Rommer P; Zierfuss B; Altmann P; Foiani M; Heslegrave A; Zetterberg H; Gleiss A; Musolino PL; Gong Y; Forss-Petter S; Berger T; Eichler F; Aubourg P; Köhler W; Berger J
Nat Commun; 2021 Mar; 12(1):1816. PubMed ID: 33753741
[TBL] [Abstract][Full Text] [Related]
37. Acute hepatic porphyrias for the neurologist: current concepts and perspectives.
Souza PVS; Badia BML; Farias IB; Gonçalves EA; Pinto WBVR; Oliveira ASB
Arq Neuropsiquiatr; 2021 Jan; 79(1):68-80. PubMed ID: 33656101
[TBL] [Abstract][Full Text] [Related]
38. Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients.
Buendía-Martínez J; Barreda-Sánchez M; Rodríguez-Peña L; Ballesta-Martínez MJ; López-González V; Sánchez-Soler MJ; Serrano-Antón AT; Pérez-Tomás ME; Gil-Ferrer R; Avilés-Plaza F; Glover-López G; Carazo-Díaz C; Guillén-Navarro E
Orphanet J Rare Dis; 2021 Feb; 16(1):106. PubMed ID: 33639982
[TBL] [Abstract][Full Text] [Related]
39. The dazzling rise of neurofilaments: Physiological functions and roles as biomarkers.
Bomont P
Curr Opin Cell Biol; 2021 Feb; 68():181-191. PubMed ID: 33454158
[TBL] [Abstract][Full Text] [Related]
40. Blood neurofilament light: a critical review of its application to neurologic disease.
Barro C; Chitnis T; Weiner HL
Ann Clin Transl Neurol; 2020 Dec; 7(12):2508-2523. PubMed ID: 33146954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
